Changing impact of gastroesophageal reflux in medical and otolaryngology practice

Laryngoscope

Volumn 115, Issue 7, 2005, Pages 1145-1153

  Altman, Kenneth W ^a,b   Stephens, Robbin M ^a   Lyttle, Christopher S ^a   Weiss, Kevin B ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Aerodigestive tract disease; Asthma; Epidemiology; Gastroesophageal reflux; National Ambulatory Medical Care Survey; Physician counseling; Tobacco use

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; NON PRESCRIPTION DRUG; PROTON PUMP INHIBITOR;

ADULT; AMBULATORY CARE; ARTICLE; COUNSELING; DIET; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH CARE DELIVERY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MEDICAL SPECIALIST; OTORHINOLARYNGOLOGY; PATIENT EDUCATION; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SMOKING CESSATION; STRESS; TOBACCO DEPENDENCE;

ADOLESCENT; ADULT; AMBULATORY CARE; ASTHMA; COUNSELING; FEMALE; FOOD HABITS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASES; HUMANS; LARYNGITIS; MALE; MIDDLE AGED; OFFICE VISITS; OTOLARYNGOLOGY; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE; RETROSPECTIVE STUDIES; TOBACCO USE DISORDER; UNITED STATES;

EID: 21844448881     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MLG.0000165464.75164.E5     Document Type: Article

References (64)

1. Kambic V, Radsei Z. Acid posterior laryngitis. Aetiology, histology, diagnosis and treatment. J Laryngol Otol 1984;98: 1237-1240.
2. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991;101:1-78.
3. Weiner GJ, Koufman JA, Wu W, et al. Chronic hoarseness secondary to gastroesophageal reflux disease: documentation with 24-h ambulatory pH monitoring. Am J Gastroenterol 1989;84:1503-1508.
4. Freije JE, Beatty TW, Campbell BH, et al. Carcinoma of the larynx in patients with gastroesophageal reflux. Am J Otolaryngol 1996;17:386-390.
5. Johanson JF. Epidemiology of esophageal and supraesophageal reflux injuries. Am J Med 2000;108:998-1038.
6. Altman KW, Simpson CB, Amin MR, et al. Cough and paradoxical vocal fold motion. Otolaryngol Head Neck Surg 2002;127:501-511.
7. Halstead LA. Role of gastroesophageal reflux in pediatric upper airway disorders. Otolaryngol Head Neck Surg 1999; 120:208-214.
8. Wetmore RF. Effects of acid on the larynx of the maturing rabbit and their possible significance to the sudden infant death syndrome. Laryngoscope 1993;103:1242-1254.
9. Penzel T, Becker HF, Brandenburg U, et al. Arousal in patients with gastro-oesophageal reflux and sleep apnoea. Eur Respir J 1999;14:1266-1270.
10. Senior BA, Kahn M, Schwimmer C, et al. Gastroesophageal reflux and obstructive sleep apnea. Laryngoscope 2001; 111:2144-2146.
11. Valipour A, Makker HK, Hardy R, et al. Symptomatic gastroesophageal reflux in subjects with a breathing sleep disorder. Chest 2002;121:1748-1753.
12. Loehrl TA, Smith TL, Darling RJ, et al. Autonomic dysfunction, vasomotor rhinitis, and extraesophageal manifestations of gastroesophageal reflux. Otolaryngol Head Neck Surg 2002;126:382-387.
13. Ulualp SO, Toohill RJ, Hoffmann R, Shaker R. Possible relationship of gastroesophagopharyngeal acid reflux with pathogenesis of chronic sinusitis. Am J Rhinol 1999;13: 197-202.
14. Bothwell MR, Parsons DS, Talbot A, et al. Outcome of reflux therapy on pediatric chronic sinusitis. Otolaryngol Head Neck Surg 1999;121:255-262.
15. Cotencin P, Narcy P. Nasopharyngeal pH monitoring in infants and children with chronic rhinopharyngitis. Int J Ped Otorhinolaryngol 1991;22:249-256.
16. Cherry DK, Burt CS, Woodwell DA. National Ambulatory Medical Care Survey: 2001 Summary. Advance Data From Vital and Health Statistics, no 337. Hyattsville, MD: National Center for Health Statistics, 2003.
17. Public Use Data Tape Documentation: 1990 National Ambulatory Medical Care Survey. Appendix I. Relative Standard Errors. Hyattsville, MD: National Center for Health Statistics, 1992.
18. Public Use Data Tape Documentation: 1991 National Ambulatory Medical Care Survey. Appendix I. Relative Standard Errors. Hyattsville, MD: National Center for Health Statistics, 1993.
19. Public Use Data Tape Documentation: 1992 National Ambulatory Medical Care Survey. Appendix I. Relative Standard Errors. Hyattsville, MD: National Center for Health Statistics, 1994.
20. Public Use Data Tape Documentation: 1993 National Ambulatory Medical Care Survey. Hyattsville, MD: National Center for Health Statistics, 1995. Supplement to the 1993-1994 File Documentation (5/19/2003).
21. StataCorp. Stata Statistical Software: Release 8. College Station, TX: Stata Corporation, 2003.
22. Kiljander T, Salomaa E-R, Heitanen E, et al. Asthma and gastro-oesophageal reflux: can response to anti-reflux therapy be predicted? Respir Med 2001;95:387-392.
23. McDougall NI, Johnston BT, Collins JS, et al. Three- to 4.5-year prospective study of prognostic indicators in gastro-oesophageal reflux disease. Scared J Gastroenterol 1998;33:118-122.
24. Biddle SJ, Gorely T, Marshall SJ, et al. Physical activity and sedentary behaviours in youth: issues and controversies. J R Soc Health 2004;124:29-33.
25. Arluk SL, Branch JD, Swain DP, Dowling EA. Childhood obesity's relationship to time spent in sedentary behavior. Mil Med 2003;168:583-586.
26. Utter J, Neumark-Sztainer D, Jeffrey R, Story M. Couch potatoes or french fries: are sedentary behaviors associated with body mass index, physical activity, and dietary behaviors among adolescents? J Am Diet Assoc 2003;103: 1298-1305.
27. Johnston BT, Lewis SA, Love AH. Psychological factors in gastro-oesophageal reflux disease. Gut 1995;36:481-482.
28. Bradley LA, Richter JE, Pulliam TJ, et al. The relationship between stress and symptoms of gastroesophageal reflux: the influence of psychological factors. Am J Gastroenterol 1993;88:11-19.
29. Peters MN, Richardson CT. Stressful life events, acid hypersecretion, and ulcer disease. Gastroenterology 1983;84: 114-119.
30. Colombo P, Mangano M, Bianchi PA, Penagini R. Effect of calories and fat on postprandial gastro-oesophageal reflux. Scan J Gastroenterol 2002;37:3-5.
31. Meining A, Classen M. The role of diet and lifestyle measures in the pathogenesis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2000;95:2692-2697.
32. Pehl C, Pfeiffer A, Waizenhoefer A, et al. Effect of caloric density of a meal on lower oesophageal sphincter motility and gastro-oesophageal reflux in healthy subjects. Aliment Pharmacol Ther 2001;15:233-239.
33. Pehl C, Waizenhoefer A, Wendl B, et al. Effect of low and high fat meals on lower esophageal sphincter motility and gastroesophageal reflux in healthy subjects. Am J Gastroenterol 1999;94:1192-1196.
34. Rodriguez S, Miner P, Robinson M, et al. Meal type affects heartburn severity. Dig Dis Sci 1998;43:485-490.
35. Pehl C, Pfeiffer A, Wendl B, Kaess H. The effect of decaffeination of coffee on gastero-oesophageal reflux in patients with reflux disease. Aliment Pharmacol Ther 1997;11: 483-486.
36. Wendl B, Pfeiffer A, Pehl C, et al. Effect of decaffeination of coffee or tea on gastro-oesophageal reflux. Alimen Pharmacol Ther 1994;8:283-287.
37. Surveillance for asthma: United States, 1960-1995. In: CDC Surveillance Summaries, April 24, 1998. MMWR 1998;47: SS-1.
38. Woodruff PG, Fahy JV. "Asthma: prevalence, pathogenesis, and prospects for novel therapies. JAMA 2001;286: 395-398.
39. Bowrey DJ, Peters JH, DeMeester TR. Gastroesophageal reflux disease in asthma. Effects of medical and surgical antireflux therapy on asthma control. Ann Surg 2000;231: 161-172.
40. Field SK, Gelfand GA, McFadden SD. The effects of antireflux surgery on asthmatics with gastroesophageal reflux. Chest 1999;116:766-774.
41. Kiljander T, Salomaa E-R, Heitanen E. Gastroesophageal reflux in asthmatics. A double-blind, placebo-controlled crossover study with omeprazole. Chest 1999;116: 1257-1264.
42. Levin TR, Sperling RM, McQuaid KR. "meprazole improves peak expiratory flow rate and quality of life in asthmatics with gastroesophageal reflux. Am J Gastroenterol 1998;93: 1060-1063.
43. Sontag SJ. Gastroesophageal reflux and asthma. Am J Med 1997;103:84S-90S.
44. Mishra A, Hogan SP, Brandt EB, Rothenberg ME. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest 2001;107:83-90.
45. Rothenberg ME, Mishra A, Collins MH, Putnam PE. Pathogenesis and clinical features of eosinophilic esophagitis. J Allergy Clin Immunol 2001;108:891-894.
46. Walsh SV, Antonioli DA, Goldman H, et al. Allergic esophagitis in children: a clinicopathologic entity. Am J Surg Path 1999;23:390-396.
47. Holtmann G. "Reflux disease: the disorder of the third millennium. Euro J Gastroenterol Hepatol 2001;13(suppl 1): S5-S11.
48. Sonnenberg A, El-Serag HB. Clinical epidemiology and natural history of gastroesophageal reflux disease. Yale J Biol Med 1999;72:81-92.
49. Pera M, Cameron AJ, Trastek VF, et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510-513.
50. Labenz J, Blum AL, Bayerdorffer E, et al. Curing Heliobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997;1442-1447.
51. Eisen G. The epidemiology of gastroesophageal reflux disease: what we know and what we need to know. Am J Ganstroenterol 2001;96(8 Suppl):S16-S18.
52. Haque M, Wyeth JW, Stace NH, et al. Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study. N Z Med J 2000;113: 178-181.
53. Kennedy T, Jones R. The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther 2000;14:1589-1594.
54. Louis E, DeLooze D, Deprez P, et al. Heartburn in Belgium: prevalence, impact on daily life, and utilization of medical resources. Euro J Gastroenterol Hepatol 2002;14:279-284.
55. Sonnenberg A. Esophageal diseases. In: Everhart JE, ed. Digestive Diseases in the United States: Epidemiology and Impact. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease. NIH publication no. 94-1447. Washington, DC: US Government Printing Office, 1994:300-355.
56. Glessner MR, Heller DA. Changes in related drug class utilization after market withdrawal of Cisapride. Am J Manag Care 2002;8:243-250.
57. Fackler WK, Ours TM, Vaezi MF, Richter JE. Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough. Gastroenterology 2002;122:625-632.
58. Hanson DG, Kamel PL, Kahrilas PJ. Outcomes of antireflux therapy for the treatment of chronic laryngitis. Ann Otol Rhinol Laryngol 1995;104:550-555.
59. Zachry WM III, Shepherd MD, Hinich MJ, et al. Relationship between direct-to-consumer advertising and physician diagnosing and prescribing. Am J Health Syst Pharm 2002; 59:42-49.
60. Williams JR, Hensel PJ. Direct-to-consumer advertising of prescription drugs. J Health Care Mark 1995;15:35-41.
61. Kessler DA, Pines WL. The federal regulation of prescription drug advertising and promotion. JAMA 1990;264: 2409-2415.
62. Hollon MF. Direct-to-consumer marketing of prescription drugs: creating consumer demand. JAMA 1999;281: 382-384.
63. Tomar SL. Trends and patterns of tobacco use in the United States. Am J Med Sci 2003;326:248-254.
64. Woodwell DA. Office visits to otolaryngologists 1989-1990, National Ambulatory Medical Care Survey. In: Vital and Health Statistics of the Centers for Disease Control and Prevention, Advance Data. 1992;222:1-11.